Anterior Segment Bioavailability
Anterior Segment Bioavailability is a pharmacokinetic metric that quantifies the extent and rate of drug delivery to the anterior segment of the eye following topical administration, distinguishing it from systemic or posterior segment bioavailability by focusing on localized ocular exposure.
2
Publications
67
Citations
10
Authors
6
Institutions
Publications per year
2017–2026
1
Parents
2
1–2 of 2
10
1
h-index
1
h-index
1
h-index
1
h-index
1
h-index
1–5 of 10
6

University of Helsinki
Helsinki, Finland
1 h-index
5 publications
265 citations

St Petersburg University
Saint Petersburg, Russia
1 h-index
1 publications
53 citations

University of Eastern Finland
Joensuu, Finland
1 h-index
1 publications
53 citations
Stanford Medicine
Stanford, United States
1 h-index
1 publications
14 citations
Ludwig-Maximilians-Universität München
Munich, Germany
1 h-index
1 publications
14 citations
Stanford University
Stanford, United States
1 h-index
5 publications
70 citations
1–6 of 6
1 publications · 53 citations
1
h-index
1 publications · 14 citations
1
h-index
1–2